Avicanna Inc. (TSX:AVCN)
Canada · Delayed Price · Currency is CAD 0.2200
0.00 (0.00%)
Jan 20, 2026, 3:59 PM EST
Avicanna Revenue
Avicanna had revenue of 6.40M CAD in the quarter ending September 30, 2025, with 1.96% growth. This brings the company's revenue in the last twelve months to 25.50M, up 2.41% year-over-year. In the year 2024, Avicanna had annual revenue of 25.46M with 51.62% growth.
Revenue (ttm)
25.50M
Revenue Growth
+2.41%
P/S Ratio
1.02
Revenue / Employee
293.05K
Employees
87
Market Cap
25.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.46M | 8.67M | 51.62% |
| Dec 31, 2023 | 16.79M | 12.74M | 314.82% |
| Dec 31, 2022 | 4.05M | 778.98K | 23.83% |
| Dec 31, 2021 | 3.27M | 1.70M | 108.20% |
| Dec 31, 2020 | 1.57M | 1.40M | 833.16% |
| Dec 31, 2019 | 168.25K | 50.28K | 42.62% |
| Dec 31, 2018 | 117.97K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 209.79M |
| 1CM Inc. | 73.37M |
| Rubicon Organics | 57.19M |
| MediPharm Labs | 46.10M |
| Leef Brands | 45.21M |
| Simply Solventless Concentrates | 33.70M |
| Greenway Greenhouse Cannabis | 8.46M |